| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 9K8GNJ2874 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Disialoganglioside GD2 binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sarcoma, Ewing | 2 | D012512 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297984 |
| FDA SRS | 9K8GNJ2874 |
CONTENTS